千金药业：2025年前三季度净利润约1.87亿元

Group 1 - Company reported Q3 performance with revenue of approximately 2.718 billion yuan, a year-on-year increase of 0.14% [1] - Net profit attributable to shareholders was about 187 million yuan, reflecting a year-on-year increase of 11.47% [1] - Basic earnings per share reached 0.4477 yuan, up 12.94% year-on-year [1] Group 2 - The current market capitalization of the company is 5.1 billion yuan [2]